 Home > Active Ingredient News > Antitumor Therapy > JEADV: Aromatase inhibitors in the treatment of 2 cases of fibrous alopecia on the frontal area of breast cancer patients

JEADV: Aromatase inhibitors in the treatment of 2 cases of fibrous alopecia on the frontal area of breast cancer patients

 Last Update: 2022-04-23
 Source: Internet
 Author: User

Tags

latuda 20 mg

mg 20

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

breast cancer

screening

Figure 1 Anterior hairline regression in postmenopausal women with hormone receptor-positive breast cancer after 18 months of treatment with anastrozole

Figure 2 Receding forehead hairline in a patient with hormone receptor-positive breast cancer four months after taking anastrozole

FFA is characterized by the immune -privileged collapse

immune stem cells

We had hypothesized that miniaturized hairs in the androgen-sensitive zone were the targets of FFA, so that 5ARI synergistically minimized further damage to follicle targets and the development of scarring alopecia

Source:Murad A, Wolinska A, Bergfeld WF,Frontal fibrosing alopecia in breast cancer patients on aromatase-inhibitor: 2 cases.

Murad A, Wolinska A, Bergfeld WF,Frontal fibrosing alopecia in breast cancer patients on aromatase-inhibitor: 2 cases.

leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

JEADV: Aromatase inhibitors in the treatment of 2 cases of fibrous alopecia on the frontal area of ​​breast cancer patients

JEADV: Aromatase inhibitors in the treatment of 2 cases of fibrous alopecia on the frontal area of breast cancer patients